Diagnóstico y tratamiento del nódulo tiroideo en España. Resultados de una encuesta nacional
Ana María Gómez‐Pérez(Hospital Clínico Universitario Virgen de la Victoria), Juan C. Galofré(Instituto de Salud Pública de Navarra), Anna Lucas-Martín(Hospital Universitari Germans Trias i Pujol), Edelmiro Menéndez Torre(Universidad de Oviedo), José Carlos Fernández‐García(Hospital Universitario Puerta de Hierro Majadahonda), Pedro Iglesias(Hospital Universitario Puerta de Hierro Majadahonda), Cristina Álvarez‐Escolá(Hospital Universitario La Paz), Juan J. Díez(Instituto Cajal), Beatriz Lecumberri(Hospital Universitario La Paz), Carmen Cabrejas-Gómez(Hospital Clínico Universitario Lozano Blesa), Sergio Donnay(Hospital Universitario Fundación Alcorcón)
Cited by 4
Related Papers
Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement
|Nature Reviews Endocrinology|2018|346
Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients
|Endocrine Related Cancer|2015|204
From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network
|European Journal of Endocrinology|2016|174
Pazopanib in pretreated advanced neuroendocrine tumors: a phase II, open-label trial of the Spanish Task Force Group for Neuroendocrine Tumors (GETNE)
|Annals of Oncology|2015|157
GLUT1 deficiency and other glucose transporter diseases
|European Journal of Endocrinology|2004|145